Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in endometrial cancer.

W T Creasman1, G L Eddy

  • 1Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston 29425.

Seminars in Surgical Oncology
|January 1, 1990
PubMed
Summary

Prognostic factors help identify early-stage endometrial cancer patients at high risk for recurrence. This led to revised staging, improving surgical and adjuvant therapy for high-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carcinoma of the Vagina.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Carcinoma of the Corpus Uteri.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Carcinoma of the Fallopian Tube.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Carcinoma of the Ovary.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Carcinoma of the Vulva.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Gestational Trophoblastic Neoplasia.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Clinical Staging

Background:

  • Clinical stage I endometrial adenocarcinoma has identifiable prognostic factors.
  • These factors stratify patients into high-risk and low-risk groups for disease recurrence.
  • Accurate risk stratification allows for tailored treatment strategies.

Purpose of the Study:

  • To highlight the importance of prognostic factors in clinical stage I endometrial adenocarcinoma.
  • To explain the shift from clinical to surgical/histopathological staging by FIGO.
  • To emphasize the role of prognostic factors in optimizing patient management.

Main Methods:

  • Review of prognostic factors for clinical stage I endometrial adenocarcinoma.
  • Analysis of the International Federation of Gynecologists and Obstetricians (FIGO) staging revision in 1988.
  • Correlation of prognostic indicators with treatment strategies.

Main Results:

  • Well-defined prognostic factors exist for clinical stage I endometrial adenocarcinoma.
  • These factors effectively identify patients at high versus low risk for recurrence.
  • The FIGO staging revision in 1988 reflected a move towards surgical/histopathological evaluation.

Conclusions:

  • Utilizing prognostic factors improves the initial surgical approach for endometrial cancer.
  • Adjuvant therapy can be more effectively tailored for high-risk patients based on these factors.
  • Surgical/histopathological evaluation enhances risk assessment and treatment planning for endometrial adenocarcinoma.

Related Experiment Videos